CoQ10 and Brain Health: What the Trials Have Found

7 August 2025, by SANUSq Research team
13 min reading time

Glowing illustration of a human brain connected to a network of neurons

The brain is one of the most energy-hungry organs in the body, and coenzyme Q10 sits at the heart of how cells make energy. The idea of a CoQ10 brain health boost is appealing, and it has been tested properly in people. What those trials found deserves an honest telling, because it is not what most pages on the subject suggest.

Written by SANUSq Research Team | Medically reviewed by Dr Ajay Kumar, MD
Published: 7 August 2025 | Updated: 7 August 2025

Why the idea seemed so promising

Coenzyme Q10 (CoQ10) is a fat-soluble compound found in almost every cell. It has two main jobs. Inside the mitochondria, it helps carry electrons along the chain of reactions that produces ATP, the cell's energy currency. It also acts as an antioxidant within cell membranes.

The brain uses roughly a fifth of the body's energy while making up only a small share of its weight, and nerve cells are sensitive to oxidative stress. Several neurodegenerative conditions, including Parkinson's disease and Huntington's disease, involve documented problems with mitochondrial function. In laboratory and animal models of Parkinson's, CoQ10 reduced the loss of dopamine-producing neurons, and an early, smaller human study hinted at a possible benefit.

So there were good reasons to run large, well-designed trials. That is exactly what happened.

What the big trials found

Parkinson's disease: the QE3 trial

The Parkinson Study Group QE3 Investigators (2014) randomly assigned 600 people with early Parkinson's disease to placebo, 1,200 mg or 2,400 mg of CoQ10 a day, with all participants also taking vitamin E. The trial was stopped early after reaching a pre-set futility threshold. CoQ10 was safe and well tolerated, but showed no evidence of clinical benefit; both CoQ10 groups in fact showed slight, non-significant adverse trends compared with placebo.

These were very high doses, tested in the condition where the scientific case was strongest. A meta-analysis pooling the available trials reached the same conclusion.

Zhu et al. (2017) combined eight randomised trials involving 899 people with Parkinson's disease. CoQ10 was well tolerated but was no better than placebo for motor symptoms or for overall Parkinson's rating scores, and the authors concluded that it could not be recommended for routine treatment.

Huntington's disease: the 2CARE trial

In the 2CARE trial, McGarry et al. (2017) gave 609 people with early Huntington's disease either 2,400 mg of CoQ10 a day or placebo, with planned follow-up of five years. An interim analysis showed so little chance of success that the trial was ended early. There were no significant differences between the groups on any primary or secondary outcome, and the authors concluded the results do not justify using CoQ10 to slow functional decline in Huntington's disease.

Two large, carefully run trials, two clear negatives. They don't prove that CoQ10 is useless everywhere, but they close a door that many websites still present as open.

CoQ10 and memory: where the evidence stands

If you have searched for "CoQ10 memory" or the benefits of CoQ10 for the brain, you will find plenty of confident claims. The human evidence behind them is thin. In healthy people, there is no convincing demonstration that CoQ10 supplements improve memory, attention or processing speed.

Much of the research is in cells or animals, or measures markers such as oxidative stress rather than how people actually think and remember.

The one randomised trial in Alzheimer's disease that included CoQ10 was small and short, and it was designed to look at biological markers rather than at whether people's memory improved.

Galasko et al. (2012) randomised 78 people with mild to moderate Alzheimer's disease to an antioxidant combination (vitamins E and C with alpha-lipoic acid), CoQ10 at 400 mg three times a day, or placebo for 16 weeks. CoQ10 did not change cerebrospinal fluid markers linked to amyloid, tau or oxidative stress.

Saying that an idea is biologically plausible is not the same as saying it works. The Parkinson's and Huntington's trials show exactly that gap.

Why a strong hypothesis can still fail

Researchers have suggested several reasons why CoQ10 did not live up to its promise in the brain.

Getting there is hard. CoQ10 is a large, fat-soluble molecule that crosses the blood–brain barrier poorly, so even very high oral doses may not deliver much to the place it is needed.
Timing. By the time a neurodegenerative disease is diagnosed, a substantial share of the affected neurons may already be lost.
Imperfect models. In animal studies, damage is usually triggered suddenly with a toxin, which is quite unlike a human disease that develops over decades.

The first point is backed by a recent trial in older adults, which found that higher blood levels did not necessarily mean more CoQ10 inside the tissues.

Schmücker et al. (2026) gave 40 healthy adults with an average age of 74 either 400 mg of CoQ10 a day or placebo for 12 weeks. Plasma CoQ10 rose significantly, but levels in muscle tissue and in isolated mitochondria did not change, and there was no improvement in mitochondrial function, glucose control or physical performance.

Where the evidence for CoQ10 is better

None of this means CoQ10 is without interest. Its stronger evidence simply lies elsewhere.

Migraine

Migraine is the one neurological area where the signal leans in a favourable direction, although the trials are small.

In a randomised, placebo-controlled trial of 42 people with migraine, Sándor et al. (2005) found that 100 mg of CoQ10 three times a day reduced attack frequency, headache days and days with nausea by the third month. Around 48% of those taking CoQ10 had at least a halving of attack frequency, compared with about 14% on placebo.

A meta-analysis by Sazali et al. (2021), pooling six trials with 371 adults, found that CoQ10 was associated with fewer migraine attacks and shorter attacks, but no significant reduction in headache severity.

Migraine is a medical condition, and frequent or changing headaches should be assessed by a doctor. If you are considering CoQ10 alongside your current approach, discuss it with your GP or neurologist rather than replacing anything you have been prescribed.

The heart

CoQ10's most substantial body of research concerns heart failure, where it has been studied as an add-on to standard care.

Xu et al. (2024) analysed 33 randomised trials in people with heart failure. CoQ10 given alongside usual treatment was associated with lower rates of death and hospital admission, along with better heart pumping function and six-minute walking distance, without major adverse effects. Several outcomes were rated as low-quality evidence.

Heart failure must be managed by a cardiologist. These findings concern CoQ10 as an addition to medical treatment, never a replacement for it.

Statins and CoQ10 levels

Statins work by blocking an enzyme in the same pathway the body uses to make CoQ10, so it is no surprise that they lower blood levels.

A meta-analysis of placebo-controlled trials by Banach et al. (2015) found that statin treatment significantly reduced plasma CoQ10 levels, across all four statins studied. The authors noted that the clinical relevance of this drop still needs to be established.

In a systematic review of five studies with around 800 people who had statin-associated muscle symptoms, Ahmad et al. (2024) reported that the included trials showed an improvement in symptoms with CoQ10, sometimes alongside a reduced statin dose. The evidence base is small, so this remains an area of research rather than settled practice.

If you take a statin and have muscle aches, speak to your doctor. Do not stop or change your statin on your own: these medicines have strong evidence for reducing heart attacks and strokes.

Ubiquinol vs ubiquinone

CoQ10 exists in two forms: ubiquinone, the oxidised form, and ubiquinol, the reduced form. The body converts one into the other as needed, and in most people this works well.

Ubiquinol is often marketed as better absorbed. That is plausible and is sometimes seen in blood levels, but there is no solid evidence that it leads to better clinical outcomes, and it usually costs considerably more. If absorption is the concern, taking CoQ10 with a meal that contains some fat helps, and formulations designed for bioavailability, such as liposomal forms, aim at the same step.

CoQ10 brain health claims vs what matters more

The factors with the best evidence for an ageing brain are not molecules at all. Regular physical activity comes top for cognitive function in later life. Good sleep follows, since it is essential for consolidating memories. After that come keeping blood pressure and blood sugar in a healthy range, getting hearing loss checked and treated, staying mentally and socially engaged, and eating a diet rich in vegetables, fish and olive oil.

None of this is glamorous, but it is where the evidence points. If you notice changes in memory, concentration or movement, see your doctor: early assessment matters far more than any supplement.

If you decide to take it anyway

Take it with food. CoQ10 is fat-soluble, so a meal containing some fat improves absorption.
Expect it to be well tolerated. Reported side effects are usually mild and digestive.
Check with your doctor if you take warfarin. CoQ10 has a structure similar to vitamin K and has been reported to affect warfarin's blood-thinning effect, so your INR may need monitoring.
Tell your doctor about any heart or neurological treatment before you start.
Never use it in place of prescribed treatment, especially for a progressive neurological condition.

The bottom line

CoQ10 is an important molecule in cell biology. In the conditions where the case looked strongest, Parkinson's and Huntington's disease, large trials found no benefit. There is no good evidence that it improves memory in healthy people. Its more promising findings are in heart failure and, more modestly, migraine. Knowing where the evidence stops is what lets you trust the rest of it.

Frequently asked questions

Is CoQ10 good for the brain?

The evidence does not show it. Large, high-dose trials in early Parkinson's disease and early Huntington's disease were both stopped early because CoQ10 showed no benefit over placebo, despite a strong biological rationale.

Does CoQ10 improve memory?

There is no convincing evidence that CoQ10 improves memory, attention or processing speed in healthy people. Most of the supportive research comes from animal studies or from intermediate markers rather than measures of how people think and remember.

Can CoQ10 help with migraines?

Small trials and a meta-analysis suggest CoQ10 may be associated with fewer and shorter migraine attacks, though not less severe ones. Migraine should be managed with your doctor, and CoQ10 should not replace prescribed treatment.

Do statins lower CoQ10 levels?

Yes. A meta-analysis of placebo-controlled trials found that statins reduce blood CoQ10 levels, although the clinical significance is still unclear. Don't stop your statin; talk to your doctor if you have muscle aches.

Is ubiquinol better than ubiquinone?

Ubiquinol may raise blood levels more readily, but there is no solid evidence that it produces better clinical results, and the body converts one form into the other. It is also usually more expensive.

Is CoQ10 safe to take?

It is generally well tolerated, with mostly mild digestive side effects. It may interact with warfarin, so speak to your doctor first if you take a blood thinner or are on heart or neurological medication.

References

Parkinson Study Group QE3 Investigators; Beal MF, Oakes D, Shoulson I, et al. A randomized clinical trial of high-dosage coenzyme Q10 in early Parkinson disease: no evidence of benefit. JAMA Neurology. 2014;71(5):543–552. PMID 24664227
Zhu ZG, Sun MX, Zhang WL, et al. The efficacy and safety of coenzyme Q10 in Parkinson's disease: a meta-analysis of randomized controlled trials. Neurological Sciences. 2017;38(2):215–224. PMID 27830343
McGarry A, McDermott M, Kieburtz K, et al. A randomized, double-blind, placebo-controlled trial of coenzyme Q10 in Huntington disease. Neurology. 2017;88(2):152–159. PMID 27913695
Galasko DR, Peskind E, Clark CM, et al. Antioxidants for Alzheimer disease: a randomized clinical trial with cerebrospinal fluid biomarker measures. Archives of Neurology. 2012;69(7):836–841. PMID 22431837
Schmücker M, Tranberg C, Borch J, et al. Coenzyme Q10 supplementation raises plasma levels without improving mitochondrial function in older adults. GeroScience. 2026;48(6):8049–8063. PMID 41604113
Sándor PS, Di Clemente L, Coppola G, et al. Efficacy of coenzyme Q10 in migraine prophylaxis: a randomized controlled trial. Neurology. 2005;64(4):713–715. PMID 15728298
Sazali S, Badrin S, Norhayati MN, Idris NS. Coenzyme Q10 supplementation for prophylaxis in adult patients with migraine—a meta-analysis. BMJ Open. 2021;11(1):e039358. PMID 33402403
Xu J, Xiang L, Yin X, et al. Efficacy and safety of coenzyme Q10 in heart failure: a meta-analysis of randomized controlled trials. BMC Cardiovascular Disorders. 2024;24(1):592. PMID 39462324
Banach M, Serban C, Ursoniu S, et al. Statin therapy and plasma coenzyme Q10 concentrations—a systematic review and meta-analysis of placebo-controlled trials. Pharmacological Research. 2015;99:329–336. PMID 26192349
Ahmad K, Manongi NJ, Rajapandian R, et al. Effectiveness of coenzyme Q10 supplementation in statin-induced myopathy: a systematic review. Cureus. 2024;16(8):e68316. PMID 39350827

Watch on YouTube

Explore more on our channel, @SANUSqHealthSupplements.

We wish you good health on your terms.
The team at SANUSq.

PS. Curious what's currently on offer? Take a look at our latest promotions.

The health information in this article is provided for educational purposes only. Consult your healthcare professional before making any medical decisions.

Regulatory Notice

The information on our websites, blogs, and emails is provided for informational purposes only and has not been evaluated by the EMA, EFSA, or FDA. It is not intended to replace medical advice provided by your healthcare professional, and is not intended to diagnose, treat, cure, or prevent any disease. Our products are intended for adults aged 18 and over. While the vitamins and supplements mentioned may offer various health benefits, supplements and dietary changes should be considered part of an overall health plan and not a substitute for professional medical treatment. Only a qualified healthcare professional can provide personalized advice and treatment plans based on your individual health needs and medical history; you should consult your healthcare professional before taking any product(s) if you are pregnant or breastfeeding.